Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population

被引:0
|
作者
Moriyama, Kengo [1 ]
Inoue, Nagamu [1 ]
Imai, Jin [2 ]
Masuda, Yumi [3 ]
Yamada, Chizumi [3 ]
Kishimoto, Noriaki [3 ]
Takashimizu, Shinji [2 ]
Kubo, Akira [3 ]
Nishizaki, Yasuhiro [2 ]
机构
[1] Tokai Univ, Hachioji Hosp, Dept Clin Hlth Sci, Sch Med, Tokyo, Japan
[2] Tokai Univ, Dept Clin Hlth Sci, Sch Med, Hiratsuka, Kanagawa, Japan
[3] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Tokyo Hosp, Tokyo, Japan
基金
日本学术振兴会;
关键词
metabolic dysfunction-associated fatty liver disease; triglyceride to high-density lipoprotein cholesterol ratio; alanine aminotransferase; insulin resistance; triglyceride-glucose index; annual health examination; HOMEOSTASIS MODEL ASSESSMENT; TRIGLYCERIDE-GLUCOSE INDEX; ETHNIC-DIFFERENCES; MANAGEMENT; PRODUCT;
D O I
10.1089/met.2023.0116
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Recently, metabolic dysfunction-associated fatty liver disease (MAFLD), which is based on evidence of hepatic steatosis and any of the following three conditions: overweight/obesity, presence of type 2 diabetes mellitus, or evidence of metabolic dysregulation, has been proposed. It is uncertain how indices that predict insulin resistance (IR) are associated with MAFLD. Methods: Among subjects who had undergone health examinations at our hospital, 1,257 (787 men and 474 women) who underwent fatty liver evaluation, were included in this cross-sectional study. The discriminatory ability of each index for MAFLD was tested using a receiver operating characteristic curve analysis. The associations between the homeostasis model assessment-IR (HOMA-IR), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, triglyceride-glucose (TyG) index, and MAFLD were investigated using multiple logistic regression analysis. Results: The mean age and body mass index of MAFLD subjects were 58.1 years and 26.0kg/m(2) in men and 63.0 years and 26.1kg/m(2) in women, respectively. The cutoff values of HOMA-IR, TG/HDL-C ratio, and TyG index in men and women were 1.40 (area under the curve [AUC]: 0.81) and 1.90 (AUC: 0.88); 1.56 (AUC: 0.75) and 1.06 (AUC: 0.78); and 8.62 (AUC: 0.75) and 8.45 (AUC: 0.80), respectively. All indices were significantly higher in both men and women with MAFLD. In the multivariate models, the odds of MAFLD were higher among both men and women in the highest tertile than those in the lowest tertile. When subjects were divided by sex, presence of MAFLD, and alanine aminotransferase (ALT) values, all indices were significantly higher in both men and women with high ALT levels who were diagnosed with MAFLD. Conclusion: IR strongly correlated with MAFLD, particularly in subjects with high ALT levels.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [31] Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
    Miao, Lei
    Yang, Li
    Guo, Li-Sha
    Shi, Qiang-Qiang
    Zhou, Teng-Fei
    Chen, Yang
    Zhang, Huai
    Cai, Hui
    Xu, Zhi-Wei
    Yang, Shuan-Ying
    Lin, Hai
    Cheng, Zhe
    Zhu, Ming-Yang
    Nan, Xu
    Huang, Shuai
    Zheng, Ya-Wen
    Targher, Giovanni
    Byrne, Christopher D.
    Li, Yu-Ping
    Zheng, Ming-Hua
    Chen, Cheng-Shui
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (02) : 230 - 237
  • [32] FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
    Gu, Zhan
    Bi, Yan
    Yuan, Fan
    Wang, Ruirui
    Li, Dong
    Wang, Jianying
    Hu, Xiaojuan
    He, Guang
    Zhang, Lei
    Liu, Bao-cheng
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 1333 - 1341
  • [33] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [34] Metabolic dysfunction-associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
    Hong, Shan
    Hong, Zifan
    Hao, Yiwei
    Sun, Lei
    Wei, Hongshan
    MEDICINE, 2025, 104 (06) : e41455
  • [35] Association of metabolic dysfunction-associated fatty liver disease with chronic kidney disease: a Chinese population-based study
    Hu, Qian
    Chen, Yao
    Bao, Ting
    Huang, Yan
    RENAL FAILURE, 2022, 44 (01) : 1996 - 2005
  • [36] The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population
    Seo, Ji Yeon
    Cho, Eun Ju
    Kim, Min Joo
    Kwak, Min-Sun
    Yang, Jong In
    Chung, Su Jin
    Yim, Jeong Yoon
    Yoon, Ji Won
    Chung, Goh Eun
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (06) : 2953 - 2960
  • [37] Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
    Lim, Tae Seop
    Chun, Ho Soo
    Kim, Soon Sun
    Kim, Ja Kyung
    Lee, Minjong
    Cho, Hyo Jung
    Kim, Seung Up
    Cheong, Jae Youn
    GUT AND LIVER, 2023, 17 (04) : 610 - 619
  • [38] Effect of Immunosuppressive Regimens on Metabolic Dysfunction-associated Fatty Liver Disease Following Liver Transplantation
    Kang, Jing
    Zhu, Ji-Qiao
    Wang, Yan
    He, Qiang
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [39] Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models
    Zhao, Qiong-Ya
    Ge, Ling-Hong
    Zhang, Kun
    Chen, Hai-Feng
    Zhan, Xin-Xin
    Yang, Yue
    Dang, Qing-Lin
    Zheng, Yi
    Zhou, Huai-Bin
    Lyu, Jian-Xin
    Fang, He-Zhi
    ZOOLOGICAL RESEARCH, 2020, 41 (05) : 539 - 551
  • [40] De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
    Han, Ma Ai Thanda
    Olivo, Raquel
    Choi, Catherine J.
    Pyrsopoulos, Nikolaos
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (12) : 1991 - 2004